Galderma Receives Filing Acceptances for Nemolizumab in Prurigo Nodularis and Atopic Dermatitis in Four Additional Countries
ZUG, Switzerland--(BUSINESS WIRE)--May 7, 2024--
Source: valdostadailytimes.com
📰 Access Consortium News
Access Consortium News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Access Consortium. Real-time updates on events, politics, business and more.
TGA Backs MHRA's Global Recognition for Drugs
Miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
United Kingdom International Engagement Strategy European Union Access Consortium Project Orbis Comparable Overseas Regulator
Source: miragenews.com
United States, Japan and Australia added to UK fast-track medicines approvals list
The Pharmaceutical Journal from the Royal Pharmaceutical Society
Source: pharmaceutical-journal.com
Veru Inc. (NASDAQ:VERU) Q4 2022 Earnings Call Transcript
Operator: Good morning ladies and gentlemen, and welcome to Veru Inc.s Investor Conference Call. All participants will be in listen-only mode.
Source: insidermonkey.com
CSL Vifor: Kapruvia approved in Switzerland with additional regulatory decisions expected in H2 2022
Kapruvia (difelikefalin) is the first and only therapy approved through consortium filing for the treatment of chronic kidney disease (CKD)-associated pruritus in hemodialysis patients Therapy recently
United Kingdom Christopher Posner Iris Francesconi Thomas Hutter Klaus Henning Jensen Annie Spinetta
Source: finanznachrichten.de
Kapruvia® approved in Switzerland with additional regulatory decisions expected in H2 2022
Press release content from Business Wire. The AP news staff was not involved in its creation.
Source: apnews.com
Kapruvia® approved in Switzerland with additional
Kapruvia® (difelikefalin) is the first and only therapy approved through consortium filing for the treatment of chronic kidney disease (CKD)-associated...
United Kingdom Christopher Posner Iris Francesconi Thomas Hutter Klaus Henning Jensen Annie Spinetta
Source: globenewswire.com
Cara Therapeutics Secures Swiss Regulatory Approval For Chronic Kidney Disease Candidate
The Swiss Agency for Therapeutic Products (Swissmedic) has approved Cara Therapeutics’ (NASDAQ:CARA) lead candidate KORSUVA (difelikefalin) ...
United States United Kingdom Christopher Posner Drug Administration Regulatory Agency Access Consortium
Source: businessinsider.com
Looking for Tech-Savvy Educators in the Philippines
In the Philippines, science and mathematics educators go beyond the basics of social media and digital broadcasting content development to get Filipino students and teachers interested in science and technology.
Hong Kong University Of Hong Kong Hong Kong General United Kingdom Substance Work Sharing Initiative Access Consortium
Source: opengovasia.com
Akebia Therapeutics Regaining Rights to Vadadustat in the United States, Europe, China and Access Consortium Countries upon Termination of Collaboration and License Agreements with Otsuka
Akebia Therapeutics Regaining Rights to Vadadustat in the United States, Europe, China and Access Consortium Countries upon Termination of Collaboration and License Agreements with Otsuka - read this article along with other careers information, tips and advice on BioSpace
United States United Kingdom Vifor Pharma Mercedes Carrasco John Butler Mitsubishi Tanabe Pharma Corporation
Source: biospace.com